Is There Clinical Value to Prognostic Signatures in Early-Stage NSCLC?

被引：4

作者：

Bunn, Paul A., Jr. ^{[1
]}

Hirsch, Fred R. ^{[1
,2
]}

Aisner, Dara L. ^{[2
]}

机构：

[1] Univ Colorado Denver, Univ Colorado Canc Ctr, Dept Med, Div Med Oncol, Aurora, CO 80045 USA

[2] Univ Colorado Denver, Univ Colorado Canc Ctr, Dept Pathol, Aurora, CO 80045 USA

来源：

CLINICAL CANCER RESEARCH | 2014年 / 20卷 / 07期

关键词：

CELL LUNG-CANCER; ADJUVANT CHEMOTHERAPY; PREDICT SURVIVAL; VALIDATION; ASSAY; RISK;

D O I：

10.1158/1078-0432.CCR-13-3387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

pAMPK and pmTOR favorably predicted outcome in early non-small cell lung cancer (NSCLC). The differences were small. Phosphoprotein lability makes routine clinical use and validation difficult. Protein immunohistochemistry is unlikely to be clinically useful, and numerous efforts to create predictive models to select resected patients for therapy have been unsuccessful. (C) 2014 AACR.

引用

页码：1727 / 1729

页数：3

共 50 条

[21] The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma
Li, Zhuang
Peng, Jiali
Zhang, Bingxin
Zhao, Chen
Chen, Zhongshao
Xiao, Huimin
Zhang, Zhaoyang
Ma, Xinyue
Gao, Feng
Xin, Rui
Wang, Wenwei
Wang, Shuaixin
Tang, Lingliya
Zhang, Yawen
Kong, Beihua
Li, Li
Yin, Aijun
EUROPEAN JOURNAL OF CANCER, 2025, 218
[22] Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
Esbah, Onur
Oksuzoglu, Berna
INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 563 - 571
[23] Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Allibhai, Z.
Cho, B. C. J.
Taremi, M.
Atallah, S.
Hope, A.
Hwang, D.
Keshavjee, S.
Tsao, M.
Yasufuku, K.
Kim, S-W.
Bezjak, A.
EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (04) : 1039 - 1042
[24] Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer
Mao, Luning
Wu, Jianghua
Zhang, Zhongjie
Mao, Lijun
Dong, Yuejin
He, Zufeng
Wang, Haiyue
Chi, Kaiwen
Jiang, Yumeng
Lin, Dongmei
CANCERS, 2023, 15 (12)
[25] Clinical utility of multigene profiling assays in early-stage breast cancer
Chang, M. C.
Souter, L. H.
Kamel-Reid, S.
Rutherford, M.
Bedard, P.
Trudeau, M.
Hart, J.
Eisen, A.
CURRENT ONCOLOGY, 2017, 24 (05) : E403 - E422
[26] Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates?
Volpe, Stefania
Vincini, Maria Giulia
Zaffaroni, Mattia
Gaeta, Aurora
Raimondi, Sara
Piperno, Gaia
Franzetti, Jessica
Colombo, Francesca
Camarda, Anna Maria
Mastroleo, Federico
Botta, Francesca
Spaggiari, Lorenzo
Gandini, Sara
Guckenberger, Matthias
Orecchia, Roberto
Casiraghi, Monica
Jereczek-Fossa, Barbara Alicja
CANCERS, 2025, 17 (05)
[27] The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database
Cheung, Winson Y.
Shi, Qian
O'Connell, Michael
Cassidy, James
Blanke, Charles D.
Kerr, David J.
Meyers, Jeff
Van Cutsem, Eric
Alberts, Steven R.
Yothers, Greg
Sargent, Daniel J.
CLINICAL COLORECTAL CANCER, 2013, 12 (03) : 179 - 187
[28] Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection
Choi, Pil Jo
Jeong, Sang Seok
Yoon, Sung Sil
JOURNAL OF THORACIC DISEASE, 2016, 8 (01) : 152 - 160
[29] Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
Liu, Jun-Qi
Liao, Xi-Wen
Wang, Xiang-Kun
Yang, Cheng-Kun
Zhou, Xin
Liu, Zheng-Qian
Han, Quan-Fa
Fu, Tian-Hao
Zhu, Guang-Zhi
Han, Chuang-Ye
Su, Hao
Huang, Jian-Lu
Ruan, Guo-Tian
Yan, Ling
Ye, Xin-Ping
Peng, Tao
BMC GASTROENTEROLOGY, 2020, 20 (01)
[30] Prognostic significance of a complement factor H autoantibody in early stage NSCLC
Gottlin, Elizabeth B.
Campa, Michael J.
Gandhi, Rikesh
Bushey, Ryan T.
Nd, James E. Herndon
Patz, Edward F., Jr.
CANCER BIOMARKERS, 2022, 34 (03) : 385 - 392

← 1 2 3 4 5 →